Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.

Clinical outcomes using accelerated partial breast irradiation in patients with ductal carcinoma in situ.

Shah C, McGee M, Wilkinson JB, Berry S, Grills I, Wallace M, Mitchell C, Vicini F.

Clin Breast Cancer. 2012 Aug;12(4):259-63. doi: 10.1016/j.clbc.2012.04.006.

PMID:
22658839
2.

Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.

Pawlik TM, Perry A, Strom EA, Babiera GV, Buchholz TA, Singletary E, Perkins GH, Ross MI, Schecter NR, Meric-Bernstam F, Ames FC, Hunt KK, Kuerer HM.

Cancer. 2004 Feb 1;100(3):490-8.

4.

Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.

Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keisch M, Dipetrillo T, Khan D, Hudes R.

Am J Surg. 2006 Oct;192(4):427-33.

PMID:
16978943
5.

Accelerated partial breast irradiation for pure ductal carcinoma in situ.

Park SS, Grills IS, Chen PY, Kestin LL, Ghilezan MI, Wallace M, Martinez AM, Vicini FA.

Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):403-8. doi: 10.1016/j.ijrobp.2010.05.030.

PMID:
20800374
6.

Outcome after ipsilateral breast tumor recurrence in patients who receive accelerated partial breast irradiation.

Shah C, Vicini F, Keisch M, Kuerer H, Beitsch P, Haffty B, Lyden M.

Cancer. 2012 Sep 1;118(17):4126-31. doi: 10.1002/cncr.27400.

7.

Outcome after ipsilateral breast tumor recurrence in patients with early-stage breast cancer treated with accelerated partial breast irradiation.

Shah C, Wilkinson JB, Jawad M, Wobb J, Berry S, Mitchell C, Wallace M, Vicini FA.

Clin Breast Cancer. 2012 Dec;12(6):392-7. doi: 10.1016/j.clbc.2012.09.006.

PMID:
23063380
8.

Prospective multicenter trial evaluating balloon-catheter partial-breast irradiation for ductal carcinoma in situ.

Abbott AM, Portschy PR, Lee C, Le CT, Han LK, Washington T, Kinney M, Bretzke M, Tuttle TM.

Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):494-8. doi: 10.1016/j.ijrobp.2013.06.2056.

PMID:
24074922
9.

Five-year outcomes and toxicities using 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.

Shah C, Wilkinson JB, Lanni T, Jawad M, Wobb J, Fowler A, Wallace M, Chen P, Grills IS, Vicini F.

Clin Breast Cancer. 2013 Jun;13(3):206-11. doi: 10.1016/j.clbc.2012.09.020.

PMID:
23103365
10.

A single-institution review of accelerated partial breast irradiation in patients considered "cautionary" by the American Society for Radiation Oncology.

Stull TS, Catherine Goodwin M, Gracely EJ, Chernick MR, Carella RJ, Frazier TG, Barrio AV.

Ann Surg Oncol. 2012 Feb;19(2):553-9. doi: 10.1245/s10434-011-1941-7.

PMID:
21769461
11.

Feasibility of accelerated partial breast irradiation in a large inner-city public hospital.

Amin M, Gabram S, Bumpers H, Landry J, Jani AB, Diaz R, Rizzo M.

Ann Surg Oncol. 2012 Dec;19(13):4094-8. doi: 10.1245/s10434-012-2444-x.

PMID:
22732836
12.

Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up.

Antonucci JV, Wallace M, Goldstein NS, Kestin L, Chen P, Benitez P, Dekhne N, Martinez A, Vicini F.

Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):447-52. doi: 10.1016/j.ijrobp.2008.08.025.

PMID:
19058921
13.

Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO Accelerated Partial Breast Irradiation Consensus Statement Groups.

Zauls AJ, Watkins JM, Wahlquist AE, Brackett NC 3rd, Aguero EG, Baker MK, Jenrette JM, Garrett-Mayer E, Harper JL.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):21-9. doi: 10.1016/j.ijrobp.2010.08.034.

PMID:
20951508
14.

High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study.

Polgár C, Major T, Fodor J, Németh G, Orosz Z, Sulyok Z, Udvarhelyi N, Somogyi A, Takácsi-Nagy Z, Lövey K, Agoston P, Kásler M.

Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1173-81.

PMID:
15519789
15.

Impact of the number of cautionary and/or unsuitable risk factors on outcomes after accelerated partial breast irradiation.

Wobb J, Wilkinson JB, Shah C, Mitchell C, Wallace M, Ye H, Stromberg J, Grills I, Chen PY.

Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):134-8. doi: 10.1016/j.ijrobp.2013.05.030.

PMID:
23920392
16.

Outcomes of breast cancer patients with triple negative receptor status treated with accelerated partial breast irradiation.

Wilkinson JB, Reid RE, Shaitelman SF, Chen PY, Mitchell CK, Wallace MF, Marvin KS, Grills IS, Margolis JM, Vicini FA.

Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):e159-64. doi: 10.1016/j.ijrobp.2010.12.031.

PMID:
21345613
17.

Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy.

Rodrigues N, Carter D, Dillon D, Parisot N, Choi DH, Haffty BG.

Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1331-5.

PMID:
12459354
18.

Defining an optimal role for breast magnetic resonance imaging when evaluating patients otherwise eligible for accelerated partial breast irradiation.

Horst KC, Fero KE, Ikeda DM, Daniel BL, Dirbas FM.

Radiother Oncol. 2013 Aug;108(2):220-5. doi: 10.1016/j.radonc.2013.01.019.

PMID:
23597699
19.

Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.

Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1514-21.

PMID:
16005576
20.

5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial.

Strnad V, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Gutierrez Miguelez C, Slampa P, Allgäuer M, Lössl K, Polat B, Kovács G, Fischedick AR, Wendt TG, Fietkau R, Hindemith M, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Pötter R, Gall C, Malzer M, Uter W, Polgár C; Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO)..

Lancet. 2016 Jan 16;387(10015):229-38. doi: 10.1016/S0140-6736(15)00471-7.

PMID:
26494415

Supplemental Content

Support Center